These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 35733077)
1. Evaluation of an Ussing Chamber System Equipped with Rat Intestinal Tissues to Predict Intestinal Absorption and Metabolism in Humans. Guan C; Yang Y; Tian D; Jiang Z; Zhang H; Li Y; Yan J; Zhang C; Chen C; Zhang J; Wang J; Wang Y; Du H; Zhou H; Wang T Eur J Drug Metab Pharmacokinet; 2022 Sep; 47(5):639-652. PubMed ID: 35733077 [TBL] [Abstract][Full Text] [Related]
2. Comparison of Ussing Chamber and Caco-2 Model in Evaluation of Intestinal Absorption Mechanism of Compounds from Different BCS Classifications. Tian D; Yang Y; Zhang H; Du H; Zhou H; Wang T Drug Metab Bioanal Lett; 2023; 16(2):105-112. PubMed ID: 37711012 [TBL] [Abstract][Full Text] [Related]
3. Characterization of the Human Intestinal Drug Transport with Ussing Chamber System Incorporating Freshly Isolated Human Jejunum. Michiba K; Maeda K; Kurimori K; Enomoto T; Shimomura O; Takeuchi T; Nishiyama H; Oda T; Kusuhara H Drug Metab Dispos; 2021 Jan; 49(1):84-93. PubMed ID: 33087448 [TBL] [Abstract][Full Text] [Related]
4. Comprehensive study on regional human intestinal permeability and prediction of fraction absorbed of drugs using the Ussing chamber technique. Sjöberg Å; Lutz M; Tannergren C; Wingolf C; Borde A; Ungell AL Eur J Pharm Sci; 2013 Jan; 48(1-2):166-80. PubMed ID: 23103351 [TBL] [Abstract][Full Text] [Related]
5. Interplay of metabolism and transport in determining oral drug absorption and gut wall metabolism: a simulation assessment using the "Advanced Dissolution, Absorption, Metabolism (ADAM)" model. Darwich AS; Neuhoff S; Jamei M; Rostami-Hodjegan A Curr Drug Metab; 2010 Nov; 11(9):716-29. PubMed ID: 21189140 [TBL] [Abstract][Full Text] [Related]
6. Simultaneous Prediction of Intestinal Absorption and Metabolism Using the Mini-Ussing Chamber System. Kondo S; Miyake M J Pharm Sci; 2019 Jan; 108(1):763-769. PubMed ID: 30389567 [TBL] [Abstract][Full Text] [Related]
7. Prediction of drug intestinal absorption in human using the Ussing chamber system: A comparison of intestinal tissues from animals and humans. Miyake M; Koga T; Kondo S; Yoda N; Emoto C; Mukai T; Toguchi H Eur J Pharm Sci; 2017 Jan; 96():373-380. PubMed ID: 27721045 [TBL] [Abstract][Full Text] [Related]
8. Intestinal first-pass metabolism by cytochrome p450 and not p-glycoprotein is the major barrier to amprenavir absorption. Dufek MB; Bridges AS; Thakker DR Drug Metab Dispos; 2013 Sep; 41(9):1695-702. PubMed ID: 23821186 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of intestinal metabolism and absorption using the Ussing chamber system equipped with intestinal tissue from rats and dogs. Miyake M; Kondo S; Koga T; Yoda N; Nakazato S; Emoto C; Mukai T; Toguchi H Eur J Pharm Biopharm; 2018 Jan; 122():49-53. PubMed ID: 28974435 [TBL] [Abstract][Full Text] [Related]
10. Human small intestinal and colonic tissue mounted in the Ussing chamber as a tool for characterizing the intestinal absorption of drugs. Rozehnal V; Nakai D; Hoepner U; Fischer T; Kamiyama E; Takahashi M; Yasuda S; Mueller J Eur J Pharm Sci; 2012 Aug; 46(5):367-73. PubMed ID: 22418036 [TBL] [Abstract][Full Text] [Related]
11. The Ussing Chamber Assay to Study Drug Metabolism and Transport in the Human Intestine. Kisser B; Mangelsen E; Wingolf C; Partecke LI; Heidecke CD; Tannergren C; Oswald S; Keiser M Curr Protoc Pharmacol; 2017 Jun; 77():7.17.1-7.17.19. PubMed ID: 28640954 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of the permeability and P-glycoprotein efflux of carbamazepine and several derivatives across mouse small intestine by the Ussing chamber technique. Fortuna A; Alves G; Falcão A; Soares-da-Silva P Epilepsia; 2012 Mar; 53(3):529-38. PubMed ID: 22372629 [TBL] [Abstract][Full Text] [Related]
13. A Sensitive Medium-Throughput Method to Predict Intestinal Absorption in Humans Using Rat Intestinal Tissue Segments. Da Silva LC; Da Silva TL; Antunes AH; Rezende KR J Pharm Sci; 2015 Sep; 104(9):2807-12. PubMed ID: 25690454 [TBL] [Abstract][Full Text] [Related]
14. A new approach to predict human intestinal absorption using porcine intestinal tissue and biorelevant matrices. Westerhout J; van de Steeg E; Grossouw D; Zeijdner EE; Krul CA; Verwei M; Wortelboer HM Eur J Pharm Sci; 2014 Oct; 63():167-77. PubMed ID: 25046168 [TBL] [Abstract][Full Text] [Related]
15. Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs. Dahan A; Amidon GL Mol Pharm; 2009; 6(1):19-28. PubMed ID: 19248230 [TBL] [Abstract][Full Text] [Related]
16. An improved prediction of the human in vivo intestinal permeability and BCS class of drugs using the in vitro permeability ratio obtained for rat intestine using an Ussing chamber system. Li H; Jin HE; Shim WS; Shim CK Drug Dev Ind Pharm; 2013 Oct; 39(10):1515-22. PubMed ID: 22934579 [TBL] [Abstract][Full Text] [Related]
17. Biopharmaceutics classification and intestinal absorption of chikusetsusaponin IVa. Zhang W; Liu H; Liu C Biopharm Drug Dispos; 2019 Sep; 40(8):276-281. PubMed ID: 31294470 [TBL] [Abstract][Full Text] [Related]
18. A proof of concept using the Ussing chamber methodology to study pediatric intestinal drug transport and age-dependent differences in absorption. Streekstra EJ; Kiss M; van den Heuvel J; Nicolaï J; van den Broek P; Botden SMBI; Stommel MWJ; van Rijssel L; Ungell AL; van de Steeg E; Russel FGM; de Wildt SN Clin Transl Sci; 2022 Oct; 15(10):2392-2402. PubMed ID: 35962572 [TBL] [Abstract][Full Text] [Related]